Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-006858
Filing Date
2021-05-12
Accepted
2021-05-12 06:12:17
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210331x10q.htm   iXBRL 10-Q 750156
2 EX-31.1 tmb-20210331xex31d1.htm EX-31.1 14678
3 EX-31.2 tmb-20210331xex31d2.htm EX-31.2 14701
4 EX-32.1 tmb-20210331xex32d1.htm EX-32.1 7228
5 EX-32.2 tmb-20210331xex32d2.htm EX-32.2 7197
  Complete submission text file 0001558370-21-006858.txt   3851822

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20210331.xsd EX-101.SCH 37510
7 EX-101.CAL tmb-20210331_cal.xml EX-101.CAL 29208
8 EX-101.DEF tmb-20210331_def.xml EX-101.DEF 136584
9 EX-101.LAB tmb-20210331_lab.xml EX-101.LAB 354641
10 EX-101.PRE tmb-20210331_pre.xml EX-101.PRE 256906
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210331x10q_htm.xml XML 465281
Mailing Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341
Business Address 665 STOCKTON DRIVE SUITE 300 EXTON PA 19341 610-321-3700
Immunome Inc. (Filer) CIK: 0001472012 (see all company filings)

EIN.: 770694340 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39580 | Film No.: 21913367
SIC: 2834 Pharmaceutical Preparations